Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease

Código QR

Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease

Guardado en:

Detalles Bibliográficos
Autores principales:	Ewa Szczepanska-Sadowska, Noreen F. Rossi
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	aldosteronism angiotensins COVID-19 heart failure hypertension ischemia Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/e19edd5439354c9ebda3ec765146f3fe
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants
por: Marat Z. Saidov, et al.
Publicado: (2019)

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis
por: Ying Xu, et al.
Publicado: (2021)

Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
por: Karl Andersen
Publicado: (2009)

Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs
por: Darcy Adin, et al.
Publicado: (2021)

The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
por: Marina Vladimirovna Shestakova
Publicado: (2010)

Corpus luteum number and the maternal renin-angiotensin-aldosterone system as determinants of utero-placental (vascular) development: the Rotterdam Periconceptional Cohort
por: Rosalieke E. Wiegel, et al.
Publicado: (2021)

Actividad de 11 beta hidroxiesteroide dehidrogenasa tipo 2 en hipertensos chilenos
por: Mosso G,Lorena, et al.
Publicado: (2002)

Hiperaldosteronismo primario y embarazo: Lecciones obtenidas de 2 casos clínicos
por: Germain A,Alfredo M, et al.
Publicado: (2002)

Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin <styled-content style="fixed-case">II</styled-content>
por: Yoshimichi Takeda, et al.
Publicado: (2018)

Relationship between the expression of angiotensin II receptors type 1 and vasoactive regulators in arterial hypertension
por: Anna V. Logatkina, et al.
Publicado: (2020)

Polymorphism of genes-candidates of renin-angiotensin-aldosteronovy system (ACE, AGT, AGTR1) and effectiveness of treatment of arterial hypertension. Results of research in Mountain Shoria
por: Tatyana A. Mulerova, et al.
Publicado: (2021)

Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
por: Kiuchi S, et al.
Publicado: (2015)

Beneficial Effects of Angiotensin II AT1 Blocker on Cardiovascular Adverse Remodeling Due to Nitric Oxide Synthesis Blockade
por: Fernandes-Santos,Caroline, et al.
Publicado: (2006)

New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects
por: Natalia A. Dragomiretskaya, et al.
Publicado: (2021)

Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
por: Cuthbert JJ, et al.
Publicado: (2020)

Tactics of antihypertensive therapy during COVID-19 pandemic
por: Valery I. Podzolkov, et al.
Publicado: (2021)

Finger Millet Ethanol Extracts Prevent Hypertension by Inhibiting the Angiotensin-Converting Enzyme Level and Enhancing the Antioxidant Capacity in Spontaneously Hypertensive Rats
por: Se Yeong Park, et al.
Publicado: (2021)

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
por: O. K. Vikulova, et al.
Publicado: (2020)

Hiperaldosteronismo primario
por: Fardella,Carlos E, et al.
Publicado: (2008)

Exceso de mineralocorticoides en hipertensos esenciales: enfoque clínico-diagnóstico
por: Cortés P,Paola, et al.
Publicado: (2000)

Legacy in Cardiovascular Risk Factors Control: From Theory to Future Therapeutic Strategies?
por: Lucie Pothen, et al.
Publicado: (2021)

Hipertensión arterial resistente
por: Feldstein,Carlos A
Publicado: (2008)

Prescripción de fármacos bloqueadores del sistema renina angiotensina en pacientes con enfermedad renal crónica etapa 3 en atención primaria de salud
por: Alvarez,Marcel, et al.
Publicado: (2019)

Angiotensin II and the Renal Hemodynamic Response to an Isolated Increased Renal Venous Pressure in Rats
por: Xiaohua Huang, et al.
Publicado: (2021)

Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19
por: Irina E. Chazova, et al.
Publicado: (2020)

Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
por: M. O.E. Irhuma, et al.
Publicado: (2016)

Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: David S. Fedson, et al.
Publicado: (2020)

Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence
por: Korzeniowska K, et al.
Publicado: (2019)

Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity
por: Slamkova M, et al.
Publicado: (2016)

Elevación del cortisol urinario en hipertensos esenciales hiporreninémicos
por: Krall O,Paola, et al.
Publicado: (2004)

Asociación de la región microsatélite AGAT del gen receptor de mineralocorticoides con los niveles de actividad renina en hipertensos esenciales
por: Muñoz-Brauning,Carlos R, et al.
Publicado: (2005)

Efecto antihipertensivo del valsartán: Estudio multicéntrico nacional
por: Prat M.,Hernán
Publicado: (2000)

Endoplasmic Reticulum (ER) Stress in Part Mediates Effects of Angiotensin II in Pancreatic Beta Cells
por: Ramalingam L, et al.
Publicado: (2020)

Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
por: Scott M. MacKenzie, et al.
Publicado: (2021)

Insuficiencia cardíaca en hospitales chilenos: resultados del Registro Nacional de Insuficiencia Cardíaca, Grupo ICARO
por: Castro G,Pablo, et al.
Publicado: (2004)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Oghenemega Okoloko, et al.
Publicado: (2021)

Actualización en el manejo clínico de la hipertensión hiporreninémica
por: Macchiavello,Stefano, et al.
Publicado: (2019)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021)

Espironolactona aumenta los niveles circulantes de angiotensina-(1-9) y revierte el remodelado cardíaco en la hipertensión arterial experimental
por: Ocaranza,María Paz, et al.
Publicado: (2017)

Progress on Genetic Basis of Primary Aldosteronism
por: Izabela Karwacka, et al.
Publicado: (2021)